A framework for cost-effectiveness analysis from clinical trial data

被引:65
|
作者
O'Hagan, A
Stevens, JW
机构
[1] Univ Sheffield, Dept Probabil & Stat, Stat Serv Unit, Sheffield S3 7RH, S Yorkshire, England
[2] Astra Zeneca R&D Charnwood, Loughborough, Leics, England
关键词
Bayesian analysis; cost-effectiveness acceptability curve; log-normal distribution; net benefit; normal distribution; outcomes;
D O I
10.1002/hec.617
中图分类号
F [经济];
学科分类号
02 ;
摘要
We present a general Bayesian framework for cost-effectiveness analysis (CEA) from clinical trial data. This framework allows for very flexible modelling of both cost and efficacy related trial data. A common CEA technique is established for this wide class of models through linking mean efficacy and mean cost to the parameters of any given model. Examples are given in which efficacy may be measured as a continuous, binary, ordinal or time-to-event outcome, and in which costs are modelled as distributed normally, log-normally, as a mixture or non-parametrically. A case study is presented, illustrating the methodology and illuminating the role of prior information. Copyright (C) 2001 John Wiley & Sons, Ltd.
引用
收藏
页码:303 / 315
页数:13
相关论文
共 50 条
  • [41] Cost-Effectiveness Analysis of Pharmaceutical-Grade Chondroitin Sulfate for Knee Osteoarthritis Based on Individual Patient Data from a Randomized Clinical Trial
    Bruyere, Olivier
    Reginster, Jean-Yves
    ADVANCES IN THERAPY, 2025, 42 (01) : 165 - 173
  • [42] The cost-effectiveness of infliximab in the treatment of ankylosing spondylitis in Spain. Comparison of clinical trial and clinical practice data
    Kobelt, G.
    Sobocki, P.
    Mulero, J.
    Gratacos, J.
    Collantes-Estevez, E.
    Braun, J.
    SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 2008, 37 (01) : 62 - 71
  • [43] Cost-effectiveness analysis
    Stein, Sherman C.
    Malhotra, Neil R.
    Burnett, Mark G.
    JOURNAL OF NEUROSURGERY-SPINE, 2014, 20 (04) : 474 - 474
  • [44] COST-EFFECTIVENESS ANALYSIS
    GANIATS, TG
    PRIMARY CARE, 1995, 22 (02): : 307 - 318
  • [45] Cost-effectiveness analysis
    Yates, BT
    EVALUATION AND PROGRAM PLANNING, 2002, 25 (02) : 201 - 202
  • [46] COST-EFFECTIVENESS ANALYSIS
    BALAKRISHNA, S
    JOURNAL OF RURAL DEVELOPMENT, 1992, 11 (05) : 701 - 703
  • [47] The clinical effectiveness and cost-effectiveness of treat-to-target strategies in rheumatoid arthritis: a systematic review and cost-effectiveness analysis
    Wailoo, Allan
    Hock, Emma S.
    Stevenson, Matt
    Martyn-St James, Marrissa
    Rawdin, Andrew
    Simpson, Emma
    Wong, Ruth
    Dracup, Naila
    Scott, David L.
    Young, Adam
    HEALTH TECHNOLOGY ASSESSMENT, 2017, 21 (71) : 1 - +
  • [48] The Broader Opportunity Costs in the Broader Cost-Effectiveness Analysis Framework
    Vallejo-Torres, Laura
    APPLIED HEALTH ECONOMICS AND HEALTH POLICY, 2023, 21 (03) : 373 - 384
  • [49] Cost-effectiveness analysis for the implementation of the EU water framework directive
    van Engelen, Donne
    Seidelin, Christian
    van der Veeren, Rob
    Barton, David N.
    Queb, Kabir
    WATER POLICY, 2008, 10 (03) : 207 - 220
  • [50] Framework for the cost-effectiveness analysis of mammography screening for breast cancer
    Zammit, D. C.
    Hay, J. W.
    Globe, D. R.
    Sugar, C. A.
    Gauderman, W. J.
    VALUE IN HEALTH, 2007, 10 (06) : A376 - A377